JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

Search

Cencora Inc

Closed

SectorHealthcare

352.28 7.19

Overview

Share price change

24h

Current

Min

333.52

Max

362.11

Key metrics

By Trading Economics

Income

-1B

-340M

Sales

3.1B

84B

P/E

Sector Avg

45.673

84.243

EPS

3.84

Dividend yield

0.61

Profit margin

-0.406

Employees

47,000

EBITDA

-1.1B

183M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+12.66% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.61%

2.28%

Next Earnings

6 maj 2026

Next Dividend date

2 mar 2026

Next Ex Dividend date

13 lut 2026

Market Stats

By TradingEconomics

Market Cap

4.6B

71B

Previous open

345.09

Previous close

352.28

News Sentiment

By Acuity

23%

77%

41 / 352 Ranking in Healthcare

Cencora Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

5 lut 2026, 23:57 UTC

Earnings

Naver Has Record Year Despite Weaker Final Quarter

5 lut 2026, 23:45 UTC

Hot Stocks

Stocks to Watch: Amazon, Coty, Gen Digital, Roblox

5 lut 2026, 22:26 UTC

Earnings

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9% -- Update

5 lut 2026, 22:00 UTC

Earnings

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9%

5 lut 2026, 23:47 UTC

Market Talk

Global Equities Roundup: Market Talk

5 lut 2026, 23:47 UTC

Market Talk

Nikkei May Fall After U.S. Tech Stock Drops -- Market Talk

5 lut 2026, 23:43 UTC

Market Talk

Gold Falls on Spillover Impact From Cryptocurrencies' Selloff -- Market Talk

5 lut 2026, 23:37 UTC

Market Talk

Glencore Shares Look Cheap After Failed Takeover Talks -- Market Talk

5 lut 2026, 23:20 UTC

Earnings
Acquisitions, Mergers, Takeovers

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 5th Update

5 lut 2026, 23:11 UTC

Market Talk

Amazon CEO Confident in Return on $200B Investment -- Market Talk

5 lut 2026, 23:09 UTC

Earnings

Naver 2025 Net KRW1.820T Vs. Net KRW1.932T >035420.SE

5 lut 2026, 23:08 UTC

Earnings

Naver 2025 Oper Pft KRW2.208T Vs. Pft KRW1.979T >035420.SE

5 lut 2026, 23:07 UTC

Earnings

Naver 2025 Rev KRW12.035T Vs. KRW10.738T >035420.SE

5 lut 2026, 23:03 UTC

Market Talk
Earnings

REA's Update Looks Negative Despite A$200M Buyback -- Market Talk

5 lut 2026, 23:03 UTC

Earnings
Acquisitions, Mergers, Takeovers

Bitcoin Booster's $12 Billion Loss Headlines Crypto's Worst Day Since 2022 Crash -- WSJ

5 lut 2026, 23:00 UTC

Earnings

Naver 4Q Net Profit Missed FactSet-Compiled Consensus

5 lut 2026, 23:00 UTC

Earnings

Naver 4Q Net KRW164.60B Vs. Net KRW514.00B >035420.SE

5 lut 2026, 22:59 UTC

Earnings

Naver 4Q Oper Pft KRW610.60B Vs. Pft KRW542.00B >035420.SE

5 lut 2026, 22:59 UTC

Earnings

Naver 4Q Rev KRW3.195T Vs. KRW2.886T >035420.SE

5 lut 2026, 22:52 UTC

Earnings

Alphabet Stock Is Taking a Hit After Strong Earnings. Don't Panic. -- Barrons.com

5 lut 2026, 22:45 UTC

Earnings

Amazon Stock Falls Sharply on Earnings. Spending Continues to Soar. -- Barrons.com

5 lut 2026, 22:37 UTC

Market Talk

Woolworths's Profit Margin Likely Faces 2Q Squeeze -- Market Talk

5 lut 2026, 22:11 UTC

Earnings

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9% -- Update

5 lut 2026, 22:03 UTC

Earnings
Acquisitions, Mergers, Takeovers

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 4th Update

5 lut 2026, 22:01 UTC

Earnings

Reddit Stock Jumps on Earnings. CFO Cites Modest AI Spending. -- Barrons.com

5 lut 2026, 21:59 UTC

Market Talk
Acquisitions, Mergers, Takeovers

What's Next For Rio Tinto, Glencore After Deal Talks Fail? -- Market Talk

5 lut 2026, 21:51 UTC

Earnings
Acquisitions, Mergers, Takeovers

Saylor's Strategy Posts $12 Billion Quarterly Loss on Bitcoin Selloff -- WSJ

5 lut 2026, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Basic Materials Roundup: Market Talk

5 lut 2026, 21:49 UTC

Earnings

Why Google's Bad News Was Good News for Broadcom and Nvidia -- Barrons.com

5 lut 2026, 21:45 UTC

Earnings

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9%

Peer Comparison

Price change

Cencora Inc Forecast

Price Target

By TipRanks

12.66% upside

12 Months Forecast

Average 407.55 USD  12.66%

High 440 USD

Low 371 USD

Based on 12 Wall Street analysts offering 12 month price targets forCencora Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

11

Buy

1

Hold

0

Sell

Sentiment

By Acuity

41 / 352 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat